DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr | ₹3,031 Cr | ₹2,210 Cr |
What is the latest Total Debt ratio of DR REDDYS LABORATORIES ?
Year | Total Debt |
---|---|
Mar2024 | ₹2,002 Cr |
Mar2023 | ₹1,347 Cr |
Mar2022 | ₹3,385 Cr |
Mar2021 | ₹3,031 Cr |
Mar2020 | ₹2,210 Cr |
How is Total Debt of DR REDDYS LABORATORIES Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹2,002 Cr | 48.60 | |
Mar2023 | ₹1,347 Cr | -60.20 | |
Mar2022 | ₹3,385 Cr | 11.67 | |
Mar2021 | ₹3,031 Cr | 37.13 | |
Mar2020 | ₹2,210 Cr | - |
Compare Total Debt of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹112,399.8 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -0.2% |
9.5% |
12.8% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses